Medical - Instruments & Supplies
Compare Stocks
2 / 10Stock Comparison
STSS vs NXRT
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Residential
STSS vs NXRT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Instruments & Supplies | REIT - Residential |
| Market Cap | $8K | $756M |
| Revenue (TTM) | $223K | $252M |
| Net Income (TTM) | $-723K | $-32M |
| Gross Margin | -7.6% | 91.1% |
| Operating Margin | -40.9% | 11.5% |
| Total Debt | $4M | $1.56B |
| Cash & Equiv. | $864K | $14M |
STSS vs NXRT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Apr 22 | May 26 | Return |
|---|---|---|---|
| Sharps Technology, … (STSS) | 100 | 0.0 | -100.0% |
| NexPoint Residentia… (NXRT) | 100 | 33.4 | -66.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: STSS vs NXRT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
STSS is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- EPS growth -7.8%
- Lower volatility, beta 2.56, current ratio 0.61x
- 99.1% revenue growth vs NXRT's -3.2%
NXRT carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 12 yrs, beta 0.62, yield 7.1%
- 211.1% 10Y total return vs STSS's -100.0%
- Beta 0.62, yield 7.1%, current ratio 0.48x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 99.1% revenue growth vs NXRT's -3.2% | |
| Quality / Margins | -12.7% margin vs STSS's -324.8% | |
| Stability / Safety | Beta 0.62 vs STSS's 2.56 | |
| Dividends | 7.1% yield; 12-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -15.2% vs STSS's -59.9% | |
| Efficiency (ROA) | -1.7% ROA vs STSS's -4.2%, ROIC 1.1% vs -120.0% |
STSS vs NXRT — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
NXRT leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NXRT is the larger business by revenue, generating $252M annually — 1129.7x STSS's $222,722. Profitability is closely matched — net margins range from -12.7% (NXRT) to -3.2% (STSS).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $222,722 | $252M |
| EBITDAEarnings before interest/tax | -$8M | $125M |
| Net IncomeAfter-tax profit | -$723,347 | -$32M |
| Free Cash FlowCash after capex | -$10M | $79M |
| Gross MarginGross profit ÷ Revenue | -7.6% | +91.1% |
| Operating MarginEBIT ÷ Revenue | -40.9% | +11.5% |
| Net MarginNet income ÷ Revenue | -3.2% | -12.7% |
| FCF MarginFCF ÷ Revenue | -44.2% | +31.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +0.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +111.0% | 0.0% |
Valuation Metrics
Evenly matched — STSS and NXRT each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $7,830 | $756M |
| Enterprise ValueMkt cap + debt − cash | $3M | $2.3B |
| Trailing P/EPrice ÷ TTM EPS | -0.00x | -23.65x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | 18.60x |
| Price / SalesMarket cap ÷ Revenue | — | 3.01x |
| Price / BookPrice ÷ Book value/share | 0.00x | 2.52x |
| Price / FCFMarket cap ÷ FCF | — | 9.05x |
Profitability & Efficiency
NXRT leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
STSS delivers a -5.0% return on equity — every $100 of shareholder capital generates $-5 in annual profit, vs $-10 for NXRT. STSS carries lower financial leverage with a 1.89x debt-to-equity ratio, signaling a more conservative balance sheet compared to NXRT's 5.18x. On the Piotroski fundamental quality scale (0–9), NXRT scores 4/9 vs STSS's 3/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -5.0% | -10.1% |
| ROA (TTM)Return on assets | -4.2% | -1.7% |
| ROICReturn on invested capital | -120.0% | +1.1% |
| ROCEReturn on capital employed | -153.7% | +1.5% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 |
| Debt / EquityFinancial leverage | 1.89x | 5.18x |
| Net DebtTotal debt minus cash | $3M | $1.5B |
| Cash & Equiv.Liquid assets | $864,041 | $14M |
| Total DebtShort + long-term debt | $4M | $1.6B |
| Interest CoverageEBIT ÷ Interest expense | -0.20x | 0.47x |
Total Returns (Dividends Reinvested)
NXRT leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NXRT five years ago would be worth $7,705 today (with dividends reinvested), compared to $1 for STSS. Over the past 12 months, NXRT leads with a -15.2% total return vs STSS's -59.9%. The 3-year compound annual growth rate (CAGR) favors NXRT at -5.5% vs STSS's -92.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -16.5% | +2.6% |
| 1-Year ReturnPast 12 months | -59.9% | -15.2% |
| 3-Year ReturnCumulative with dividends | -100.0% | -15.5% |
| 5-Year ReturnCumulative with dividends | -100.0% | -23.0% |
| 10-Year ReturnCumulative with dividends | -100.0% | +211.1% |
| CAGR (3Y)Annualised 3-year return | -92.9% | -5.5% |
Risk & Volatility
NXRT leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NXRT is the less volatile stock with a 0.62 beta — it tends to amplify market swings less than STSS's 2.56 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NXRT currently trades 77.8% from its 52-week high vs STSS's 10.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.56x | 0.62x |
| 52-Week HighHighest price in past year | $18.23 | $38.30 |
| 52-Week LowLowest price in past year | $1.42 | $23.79 |
| % of 52W HighCurrent price vs 52-week peak | +10.3% | +77.8% |
| RSI (14)Momentum oscillator 0–100 | 55.6 | 71.0 |
| Avg Volume (50D)Average daily shares traded | 327K | 216K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
NXRT is the only dividend payer here at 7.07% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold |
| Price TargetConsensus 12-month target | — | $27.00 |
| # AnalystsCovering analysts | — | 10 |
| Dividend YieldAnnual dividend ÷ price | — | +7.1% |
| Dividend StreakConsecutive years of raises | — | 12 |
| Dividend / ShareAnnual DPS | — | $2.11 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.0% |
NXRT leads in 4 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 1 category is tied.
STSS vs NXRT: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is STSS or NXRT a better buy right now?
Analysts rate NexPoint Residential Trust, Inc.
(NXRT) a "Hold" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — STSS or NXRT?
Over the past 5 years, NexPoint Residential Trust, Inc.
(NXRT) delivered a total return of -23. 0%, compared to -100. 0% for Sharps Technology, Inc. (STSS). Over 10 years, the gap is even starker: NXRT returned +211. 1% versus STSS's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — STSS or NXRT?
By beta (market sensitivity over 5 years), NexPoint Residential Trust, Inc.
(NXRT) is the lower-risk stock at 0. 62β versus Sharps Technology, Inc. 's 2. 56β — meaning STSS is approximately 310% more volatile than NXRT relative to the S&P 500. On balance sheet safety, Sharps Technology, Inc. (STSS) carries a lower debt/equity ratio of 189% versus 5% for NexPoint Residential Trust, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — STSS or NXRT?
On earnings-per-share growth, the picture is similar: Sharps Technology, Inc.
grew EPS -782. 0% year-over-year, compared to -30. 8% for NexPoint Residential Trust, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — STSS or NXRT?
NexPoint Residential Trust, Inc.
(NXRT) is the more profitable company, earning -12. 7% net margin versus -324. 8% for Sharps Technology, Inc. — meaning it keeps -12. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NXRT leads at 11. 1% versus -40. 9% for STSS. At the gross margin level — before operating expenses — NXRT leads at 84. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — STSS or NXRT?
In this comparison, NXRT (7.
1% yield) pays a dividend. STSS does not pay a meaningful dividend and should not be held primarily for income.
07Is STSS or NXRT better for a retirement portfolio?
For long-horizon retirement investors, NexPoint Residential Trust, Inc.
(NXRT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 62), 7. 1% yield, +211. 1% 10Y return). Sharps Technology, Inc. (STSS) carries a higher beta of 2. 56 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (NXRT: +211. 1%, STSS: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between STSS and NXRT?
These companies operate in different sectors (STSS (Healthcare) and NXRT (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: STSS is a small-cap quality compounder stock; NXRT is a small-cap income-oriented stock. NXRT pays a dividend while STSS does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.